Literature DB >> 7212647

Cerebrospinal fluid biochemical markers of central nervous system metastases.

S C Schold, W R Wasserstrom, M Fleisher, M K Schwartz, J B Posner.   

Abstract

beta-Glucuronidase and carcinoembryonic antigen (CEA) were measured in the cerebrospinal fluid of patients with cancer. Both substances were found to reliably detect the presence of leptomeningeal infiltration by carcinoma. Neither substance was reliable in the detection of leptomeningeal infiltration by lymphoma or of metastases to the brain parenchyma or spinal epidural space. beta-Glucuronidase was moderately elevated in chronic infectious meningitis, whereas CEA was not. Both markers approached control levels with favorable treatment of the leptomeningeal metastases, reflecting the effectiveness of treatment. Both beta-glucuronidase and CEA hold promise as indicators of early metastatic involvement of the leptomeninges by carcinoma.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7212647     DOI: 10.1002/ana.410080609

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  16 in total

Review 1.  Meningeal metastases: clinical aspects and diagnosis.

Authors:  F Formaglio; A Caraceni
Journal:  Ital J Neurol Sci       Date:  1998-06

2.  Meningeal carcinomatosis.

Authors:  W R Shapiro
Journal:  West J Med       Date:  1991-03

Review 3.  Leptomeningeal metastases from solid malignancy: a review.

Authors:  Sophie Taillibert; Florence Laigle-Donadey; Catherine Chodkiewicz; Marc Sanson; Khê Hoang-Xuan; Jean-Yves Delattre
Journal:  J Neurooncol       Date:  2005-10       Impact factor: 4.130

4.  Cerebrospinal fluid tumour markers in patients treated for meningeal malignancy.

Authors:  A P van Zanten; A Twijnstra; B W Ongerboer de Visser; P van Heerde; A A Hart; W J Nooyen
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-02       Impact factor: 10.154

5.  Serial lumbar and ventricular cerebrospinal fluid biochemical marker measurements in patients with leptomeningeal metastases from solid and hematological tumors.

Authors:  A Twijnstra; B W Ongerboer de Visser; A P van Zanten; A A Hart; W J Nooyen
Journal:  J Neurooncol       Date:  1989-05       Impact factor: 4.130

6.  Brain metastases from colon cancer.

Authors:  T L Cascino; J M Leavengood; N Kemeny; J B Posner
Journal:  J Neurooncol       Date:  1983       Impact factor: 4.130

7.  Diagnostic value of cerebrospinal fluid level of carcinoembryonic antigen in patients with leptomeningeal carcinomatous metastasis.

Authors:  Sung Jin Kang; Kwang Soo Kim; Yoon Suk Ha; So Young Huh; Ji Hyun Lee; Jong Kuk Kim; Min Jeong Kim
Journal:  J Clin Neurol       Date:  2010-03-26       Impact factor: 3.077

8.  Serial lumbar and ventricle cerebrospinal fluid lactate dehydrogenase activities in patients with leptomeningeal metastases from solid and haematological tumours.

Authors:  A Twijnstra; A P van Zanten; A A Hart; B W Ongerboer de Visser
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-03       Impact factor: 10.154

9.  Sensitivity and specificity of single and combined tumour markers in the diagnosis of leptomeningeal metastasis from breast cancer.

Authors:  A Twijnstra; A P van Zanten; W J Nooyen; B W Ongerboer de Visser
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-11       Impact factor: 10.154

Review 10.  Current diagnosis and treatment of leptomeningeal metastasis.

Authors:  L M DeAngelis
Journal:  J Neurooncol       Date:  1998 Jun-Jul       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.